Pfizer Inc. (PFE)

41.81
0.03 0.07
NYSE : Health Technology
Prev Close 41.78
Open 41.77
Day Low/High 41.65 / 42.06
52 Wk Low/High 34.32 / 46.47
Volume 17.34M
Avg Volume 26.06M
Exchange NYSE
Shares Outstanding 5.55B
Market Cap 233.23B
EPS 1.90
P/E Ratio 21.68
Div & Yield 1.44 (3.28%)
See How Pfizer Ranks Among Analysts' Top Dow 30 Picks

See How Pfizer Ranks Among Analysts' Top Dow 30 Picks

A study of analyst recommendations at the major brokerages shows that Pfizer Inc is the #24 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Within the broader S&P 500, when components were ranked in terms of analyst favorites, PFE claims the #355 spot.

Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference

Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference

Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chief Operating Officer, at the Goldman Sachs 11 th Annual Healthcare CEOs Unscripted: A View from the Top on Thursday, January 3, 2019 at...

AbbVie: The Perfect Stock for High Yield and Growth

ABBV offers an ideal mix of growth, value and income.

Merck KGaA, Darmstadt, Germany, And Pfizer Provide Update On JAVELIN Ovarian 100 Trial Of Avelumab In Previously Untreated Advanced Ovarian Cancer

Merck KGaA, Darmstadt, Germany, And Pfizer Provide Update On JAVELIN Ovarian 100 Trial Of Avelumab In Previously Untreated Advanced Ovarian Cancer

DARMSTADT, Germany, and NEW YORK, December 21, 2018 /PRNewswire/ -- Not intended for UK-based media Merck KGaA, Darmstadt, Germany, and Pfizer Inc.

Independent Data Monitoring Committee Recommends Discontinuation Of The Phase 2b STRIVE Clinical Trial Of Staphylococcus Aureus Vaccine Following Planned Interim Analysis

Independent Data Monitoring Committee Recommends Discontinuation Of The Phase 2b STRIVE Clinical Trial Of Staphylococcus Aureus Vaccine Following Planned Interim Analysis

Pfizer Inc. (NYSE:PFE) announced today that the Phase 2b trial STRIVE ( STaphylococcus aureus SuRgical Inpatient Vaccine Efficacy) evaluating the company's investigational Staphylococcus aureus ( S.

Https://www.astellas.com/us

Https://www.astellas.com/us

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.

Stocks Hit New Lows After Early Rally as Fed Hikes Key Rate

Stocks Hit New Lows After Early Rally as Fed Hikes Key Rate

Stocks plunged Wednesday afternoon following the Federal Reserve's decision to raise rates by a quarter point.

Fed, Micron, Glaxo and Pfizer, FedEx and Facebook - 5 Things You Must Know

Fed, Micron, Glaxo and Pfizer, FedEx and Facebook - 5 Things You Must Know

U.S. stock futures rise Wednesday as investors prep for an announcement from the Federal Reserve on interest rates; Micron tumbles after a weak second-quarter sales forecast; Glaxo and Pfizer combine their consumer health businesses; FedEx slumps after lowering its outlook.

GlaxoSmithKline, Pfizer Form Consumer Healthcare Group With $13 Billion in Sales

GlaxoSmithKline, Pfizer Form Consumer Healthcare Group With $13 Billion in Sales

GlaxoSmithKline shares surged to the top of the European market Wednesday after the drugmaker said it would combine its consumer health division with U.S. rival Pfizer's to create a new division with $13 billion in annual sales.

Pfizer And GlaxoSmithKline Announce Joint Venture To Create A Premier Global Consumer Healthcare Company

Pfizer And GlaxoSmithKline Announce Joint Venture To Create A Premier Global Consumer Healthcare Company

Pfizer Inc. (NYSE: PFE) and GlaxoSmithKline plc (NYSE:GSK) today announced they have entered into an agreement to create a premier global consumer healthcare company with robust iconic brands.

Pfizer Invites Public To View And Listen To Webcast Of January 29 Conference Call With Analysts

Pfizer Invites Public To View And Listen To Webcast Of January 29 Conference Call With Analysts

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.

Seagate Technology, Macy's and a Dozen Other Dividend Stocks to Buy Here

Seagate Technology, Macy's and a Dozen Other Dividend Stocks to Buy Here

Focus on high-quality dividend payers as we move toward a possible yield-curve inversion and U.S. recession.

Kineta Enters Research Collaboration And License Agreement With Pfizer To Develop New Cancer Immunotherapies

Kineta Enters Research Collaboration And License Agreement With Pfizer To Develop New Cancer Immunotherapies

Kineta Immuno-Oncology to receive $15 million upfront and will be eligible to receive up to $505 million in potential research, development and sales milestone payments

Johnson & Johnson Shares Plunge After Report It Knew of Asbestos in Baby Powder

Johnson & Johnson Shares Plunge After Report It Knew of Asbestos in Baby Powder

Johnson & Johnson shares plunged the most in more than 15 years Friday following a report that said the company knew for decades that its iconic baby powder sometimes contained asbestos and failed to alert authorities.

Pfizer Boosts Q1 Dividend, Launches $10 Billion Buyback as Read Says Farewell

Pfizer Boosts Q1 Dividend, Launches $10 Billion Buyback as Read Says Farewell

Pfizer shares traded lower Friday even as the pharmaceutical group boosted it latest quarterly dividend and said it would buyback another $10 million in company stock in what may be the last corporate act of outgoing CEO Ian Read.

Pfizer Declares First-Quarter 2019 Dividend

Pfizer Declares First-Quarter 2019 Dividend

The board of directors of Pfizer Inc. today declared a 36-cent first-quarter 2019 dividend on the company's common stock, payable March 1, 2019, to shareholders of record at the close of business on February 1, 2019.

Pfizer Receives Positive CHMP Opinion For Oncology Biosimilar, ZIRABEV™ (bevacizumab)

Pfizer Receives Positive CHMP Opinion For Oncology Biosimilar, ZIRABEV™ (bevacizumab)

Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing authorization for ZIRABEV ™ (bevacizumab), a potential...

Pfizer Initiates Phase 3 Program For 20-Valent Pneumococcal Conjugate Vaccine For The Prevention Of Invasive Disease And Pneumonia In Adults Aged 18 Years And Older

Pfizer Initiates Phase 3 Program For 20-Valent Pneumococcal Conjugate Vaccine For The Prevention Of Invasive Disease And Pneumonia In Adults Aged 18 Years And Older

Pfizer Inc. (NYSE:PFE) announced today the initiation of a Phase 3 program for its 20-Valent pneumococcal conjugate vaccine (20vPnC) candidate, PF-06482077, for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes...

Pfizer Becomes #12 Most Shorted Dow Stock, Replacing Intel

Pfizer Becomes #12 Most Shorted Dow Stock, Replacing Intel

The most recent short interest data has been released for the 11/30/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Stocks End Mixed as China Trade Progress Offsets D.C. Dysfunction

Stocks End Mixed as China Trade Progress Offsets D.C. Dysfunction

Stocks are mixed Tuesday as Donald Trump and top Democratic leaders clash over border security.

Who Are the 9 Highest-Paid CEOs and How Much Do They Make?

Who Are the 9 Highest-Paid CEOs and How Much Do They Make?

The CEOs who bring in the most money every year may not be who you expect. Who are the highest-paid CEOs?

Pfizer Slips After JPMorgan Downgrade on Patent Cycle Concerns

Pfizer Slips After JPMorgan Downgrade on Patent Cycle Concerns

Pfizer shares slipped Tuesday after analysts at JPMorgan lowered their rating for the drugmaker amid concerns of the loss of exclusivity on one of its key pain treatments.

Wall Street Futures Jump Higher, Global Markets Rally on US-China Trade Progress

Wall Street Futures Jump Higher, Global Markets Rally on US-China Trade Progress

Global stocks edged higher Tuesday, with investors reacting cautiously to progress in U.S.-China trade talks but still unnerved by the ongoing political chaos surrounding Britain's Brexit vote, as bond investor prep for a series of Treasury auctions in the United States.

Pfizer Presents Positive 26-Week Data For PF-05280586, A Potential Biosimilar To Rituximab, At The American Society Of Hematology Annual Meeting

Pfizer Presents Positive 26-Week Data For PF-05280586, A Potential Biosimilar To Rituximab, At The American Society Of Hematology Annual Meeting

Pfizer Inc. (NYSE:PFE) announced today at the American Society of Hematology Annual Meeting that the REFLECTIONS B328-06 study, a comparative safety and efficacy study of PF-05280586 versus Rituxan ®/MabThera ® (rituximab-EU) i, met its primary endpoint...

Pfizer Is in Breakout-Mode This Fall: Chart

Pfizer Is in Breakout-Mode This Fall: Chart

This healthcare stock looks healthy for your portfolio amid the volatility.

Pfizer Reaches A Global Agreement With AbbVie

Pfizer Reaches A Global Agreement With AbbVie

Pfizer Inc. (NYSE:PFE) today announced that it has signed licensing agreements with AbbVie, resolving all global intellectual property matters for Pfizer's proposed adalimumab biosimilar.

Pfizer Receives Six Months Pediatric Exclusivity For LYRICA® (pregabalin)

Pfizer Receives Six Months Pediatric Exclusivity For LYRICA® (pregabalin)

Pfizer Inc. (NYSE: PFE) today announced that the U.

Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference

Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference

Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Chris Boshoff, senior vice president and head, Immuno-Oncology, Early Development and Translational Oncology, at the Evercore ISI HealthConX Conference on...

TheStreet Quant Rating: B (Buy)